title: Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?
abstract: The HIV epidemic in Uganda has highlighted Cryptococcus and Candida infections as important opportunistic fungal infections. However, the burden of other fungal diseases is not well described. We aimed to estimate the burden of fungal infections in Uganda. All epidemiological papers of fungal diseases in Uganda were reviewed. Where there is no Ugandan data, global or East African data were used. Recurrent vaginal candidiasis is estimated to occur in 375 540 Uganda women per year; Candida in pregnant women affects up to 651,600 women per year. There are around 45,000 HIV-related oral and oesophageal candidosis cases per year. There are up to 3000 cases per year of post-TB chronic pulmonary aspergillosis. There are an estimated 40,392 people with asthma-related fungal conditions. An estimated 1,300,000 cases of tinea capitis occur in school children yearly in Uganda. There are approximately 800 HIV-positive adults with Pneumocystis jirovecii pneumonia (PJP) annually and up to 42 000 children with PJP per year. There are an estimated 4000 cryptococcal cases annually. There are an estimated 2.5 million fungal infections per year in Uganda. Cryptococcus and PJP cause around 28,000 deaths in adults and children per year. We propose replicating the model of research around cryptococcal disease to investigate and development management strategies for other fungal diseases in Uganda.
authors.affiliation: Infectious Diseases Institute, Kampala, Uganda.
authors.forename: R
authors.initials: R
authors.lastname: Parkes-Ratanshi
authors.affiliation: Department of Microbiology, Makerere University, Kampala, Uganda.
authors.forename: B
authors.initials: B
authors.lastname: Achan
authors.affiliation: Infectious Diseases Institute, Kampala, Uganda.
authors.forename: R
authors.initials: R
authors.lastname: Kwizera
authors.affiliation: Infectious Diseases Institute, Kampala, Uganda.
authors.forename: A
authors.initials: A
authors.lastname: Kambugu
authors.affiliation: Infectious Diseases Institute, Kampala, Uganda.
authors.forename: D
authors.initials: D
authors.lastname: Meya
authors.affiliation: National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester, Manchester, UK.|Manchester Academic Health Science Centre, Manchester, UK.
authors.forename: D W
authors.initials: DW
authors.lastname: Denning
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology / Q000382:microbiology; D001228:Aspergillosis / Q000453:epidemiology / Q000382:microbiology; D002177:Candidiasis / Q000453:epidemiology / Q000382:microbiology; D017281:Cost of Illness; D003453:Cryptococcosis / Q000453:epidemiology* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D009181:Mycoses / Q000453:epidemiology* / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000382:microbiology; D014454:Uganda / Q000453:epidemiology; D014848:Vulvovaginitis / Q000453:epidemiology / Q000382:microbiology
keywords: Candida; Cryptococcus; HIV; Uganda; aspergillosis; fungal infection